SCHEMBL6931471

SCHEMBL6931471

CC1=C(C#N)[C@@H](c2cccc3ncc(-c4ccccc4)cc23)C(C(=O)OC(C)C)=C(N)N1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 4/20 0.67
KDM4E B2RXH2 2/20 0.47
CACNA1C Q13936 4/20 0.41
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 2/20 0.38
MLNR O43193 2/20 0.38
NR1I2 O75469 2/20 0.38
ADORA3 P0DMS8 2/20 0.38
SLC6A3 Q01959 2/20 0.38
KMT2A Q03164 2/20 0.38
PDE4D Q08499 2/20 0.38
ABCB11 O95342 1/20 0.38
NR3C1 P04150 1/20 0.38
CYP2C8 P10632 1/20 0.38
CYP2D6 P10635 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877495 1.00 NR3C2 (0.67) NR3C2KDM4ECACNA1CALDH1A1CYP1A2
SCHEMBL9644465 0.93 NR3C2 (0.77) NR3C2KDM4ECACNA1CCYP1A2CYP3A4
SCHEMBL8923705 0.89 NR3C2 (0.52) NR3C2KDM4ECACNA1CALDH1A1NPSR1
SCHEMBL7162892 0.89 NR3C2 (0.52) NR3C2KDM4ECACNA1CALDH1A1NPSR1
SCHEMBL7275395 0.88 NR3C2 (0.55) NR3C2KDM4ECACNA1CALDH1A1MET
SCHEMBL9123412 0.87 NR3C2 (0.54) NR3C2CACNA1C
SCHEMBL9644691 0.86 NR3C2 (0.73) NR3C2KDM4ECACNA1CALDH1A1CYP1A2
SCHEMBL9155066 0.84 NR3C2 (0.63) NR3C2KDM4ECACNA1CALDH1A1CYP1A2
SCHEMBL9467948 0.83 NR3C2 (0.62) NR3C2KDM4ECACNA1CALDH1A1CYP1A2
SCHEMBL9096711 0.83 NR3C2 (0.51) NR3C2KDM4ECACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3875078-A1 COMPOUNDS FOR THE TREATMENT OF COVID-19 Dompe' Farmaceutici S.P.A. (IT) 2021-09-08 EP claimed
EP-3875078-A1 COMPOUNDS FOR THE TREATMENT OF COVID-19 Dompe' Farmaceutici S.P.A. (IT) 2021-09-08 EP disclosed
EP-1045709-B1 METHOD AND DEVICE FOR IN-SITU FORMULATION OF A MEDICINAL SOLUTION FOR PARENTERAL APPLICATION BAYER AG (DE) 2003-12-03 EP disclosed
EP-1045709-A1 METHOD AND DEVICE FOR IN-SITU FORMULATION OF A MEDICINAL SOLUTION FOR PARENTERAL APPLICATION Bayer Aktiengesellschaft (DE) 2000-10-25 EP disclosed
WO-1999032175-A1 METHOD AND DEVICE FOR IN-SITU FORMULATION OF A MEDICINAL SOLUTION FOR PARENTERAL APPLICATION BAYER AKTIENGESELLSCHAFT (DE) 1999-07-01 WO disclosed